Surrey Heartlands

Joint Formulary & PAD

Insulin pump - non-autoimmune causes - Diabetes Mellitus

You are here : Home > Formulary Search > Insulin pump - non-autoimmune causes - Diabetes Mellitus

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Status 1

Red
Formulations :
  • Device
Formulary Status :
Primary Care
ASPH
RSFT
SASH
SABP
Associated Icons :
Guidelines SPC
ICB
Restrictions / Comments :
Important

Note; Neither Continuous Glucose Monitoring (CGM) nor Omnipod 5 is commissioned for this cohort.

Documentation

Guidelines (Local)
South East Coast & London Paediatric Diabetes Network guidelines - Insulin pumps and CGMS - Dec-17

PAD Profile

ChemicalSubstance :
Insulin pump - non-autoimmune causes
Indication :
Diabetes Mellitus
Group Name :
Keywords :
CSII, continuous subcutaneous insulin infusion, cystic fibrosis-related diabetes, congenital absence of pancreas, genetic disorders of loss of insulin formation or secretion, post-pancreatitis pancreatic destruction, post-pancreatectomy diabetes, Medtrum, Air Liquide, Ypsomed, Menarini, Advanced Therapeutics
Brand Names Include :
Omnipod DASH, Ypsopump, DANA I, Medtronic, t:slim, tslim, 780G,
Important Information :
Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Diabetes Mellitus
Supporting Documents :
1

Other Indications

Below are listed other indications that Insulin pump - non-autoimmune causes is used to treat.

  • No records returned.

Other Drugs

Below are listed other drugs that are used to treat Diabetes Mellitus.

Committee Recommendations (2)

03 Jul 24 - Surrey Heartlands Integrated Care System Area Prescribing Committee (APC)

Insulin Pump warranties

The Surrey Heartlands Integrated Care System Area Prescribing Committee have re-affirmed the position on insulin pump warranties.

The 'tethered' (with tubing) insulin pumps have a 4 year warranty. A patient can be switched 'in warranty', to another insulin pump where:

  • The Diabetes specialist team consider that the use if the current tethered insulin pump poses a safety concerns OR
  • The Diabetes specialist team consider that the patient is unable to maintain expected blood sugar levels with their current 'tethered' insulin pump.
01 Mar 23 - Surrey Heartlands Integrated Care System Area Prescribing Committee (APC)

The Surrey Heartlands Integrated Care System Area Prescribing Committee has agreed that the following insulin pumps will be available for patients with a non-autoimmune cause for deficiency of beta cells.

The decion to agree the use of insulin pumps in patient with non-autoimmune cuase for deficiency of beta cells was made by APC following the publication of the South East Coast & London Paediatric Diabetes Network guidelines in December 2018.

  • Medtronic 780g insulin Pump (Medtronic)
  • T-Slim insulin Pump (Air Liquide Healthcare Ltd)
  • Ypsopump insulin pump (Ypsomed Ltd)
  • Omnipod DASH patch pump (Insulet International Ltd)
  • Dana I (Advanced Therapeutics (UK) Ltd) – replaces Dana RS insulin pump (upgrade)
  • GlucoMen® Day Insulin Patch Pump (A. Menarini Diagnostics)
  • A8 TouchCare Nano (Medtrum Ltd)


A RED traffic light status for the insulin pumps and the consumables is agreed by APC.

Trusts should work with their procurement leads to sign up to the NHS Supplies framework so that national agreed discounts and associated savings can be realised.